UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Comparing zero-based and cash flow budgeting reveals how each method handles income allocation, expenses, and optimization opportunities.
28,655 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A data center hardware maker saw a dramatic stock drop this week amid regulatory and supply chain concerns. This guid...
Imagine a space tech powerhouse going public and shaping Wall Street expectations. This article lays out three plausi...
AI's rise depends not only on chips and servers but on the cooling and mechanical systems that keep data centers aliv...
Turn your know-how into steady income with a practical plan. This guide shows how to find your niche, price your offe...
As Medicare IRMAA surcharges loom, retirees face higher taxes on RMDs and reduced spendable cash. This report explain...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
Microsoft posts solid Q3 results, showing AI and cloud momentum that investors say could unlock value in Big Tech. Th...
The Fed’s decision to hold rates steady sent ripples through the market as inflation worries resurfaced. Here’s what ...
NVIDIA just crushed earnings on the headline numbers, yet the stock reacted oddly, slipping the next day. This guide ...